Bremner P, Burgess C, Purdie G, Beasley R, Crane J
Department of Medicine, Wellington School of Medicine, New Zealand.
Eur J Clin Pharmacol. 1993;45(1):37-9. doi: 10.1007/BF00315347.
We have investigated the cardiovascular and metabolic effects of multiple inhaled doses of salbutamol and hexoprenaline in 12 healthy volunteers. They inhaled 200 micrograms of salbutamol or hexoprenaline at 15 min intervals for 60 min from a metered dose inhaler (total dose 1000 micrograms). We measured heart rate, blood pressure, total electromechanical systole (as a measure of inotropic response), QTc interval on the ECG, and plasma potassium at baseline, 10 min after each inhalation, and 30 and 60 min after the last inhalation. There was no difference in the effects of the two drugs on blood pressure, total electromechanical systole, or QTc interval. Salbutamol significantly increased heart rate compared with hexoprenaline. Hexoprenaline caused a significantly greater fall in plasma potassium compared with salbutamol.
我们研究了多次吸入剂量的沙丁胺醇和己二烯肾上腺素对12名健康志愿者心血管和代谢的影响。他们通过定量吸入器每隔15分钟吸入200微克沙丁胺醇或己二烯肾上腺素,共吸入60分钟(总剂量1000微克)。我们在基线、每次吸入后10分钟、最后一次吸入后30分钟和60分钟测量心率、血压、总电机械收缩期(作为变力反应的指标)、心电图上的QTc间期以及血浆钾。两种药物对血压、总电机械收缩期或QTc间期的影响没有差异。与己二烯肾上腺素相比,沙丁胺醇显著增加心率。与沙丁胺醇相比,己二烯肾上腺素导致血浆钾显著下降。